Zdrowie i gospodarka · 28/02/2014

FDA Releases Draft Guidance for Industry on HIV Resistance Data Submission

The FDA has released a draft guidance to help industry sponsors submit human immunodeficiency virus (HIV) clinical virology data to support clinical trials of HIV treatment products, with the goal of accelerating the development of anti-HIV medications.